AIM ImmunoTech
Stock Forecast, Prediction & Price Target
AIM ImmunoTech Financial Estimates
AIM ImmunoTech Revenue Estimates
AIM ImmunoTech EBITDA Estimates
AIM ImmunoTech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $135K N/A | $141K 4.44% | $202K 43.26% | Avg: $1.78M Low: $139.99K High: $5M avg. 781.18% | Avg: $3.82M Low: $359.99K High: $10.4M avg. 114.60% | Avg: $9.75M Low: $918.84K High: $26.54M avg. 155.23% | Avg: $51.04M Low: $4.81M High: $138.96M avg. 423.51% |
Net Income
% change YoY
| $-21.51M N/A | $-21.08M 1.98% | $-28.96M -37.35% | Avg: $-25.62M Low: $-22.83M High: $-21.37M avg. 11.53% | Avg: $-35.38M Low: $-86.55M High: $4.74M avg. -38.11% | Avg: $-30.60M Low: $-99.15M High: $5.43M avg. 13.50% | Avg: $-8.74M Low: $-28.32M High: $1.55M avg. 71.42% |
EBITDA
% change YoY
| $-13.96M N/A | $-17.54M -25.65% | $-31.67M -80.52% | Avg: $-1.78M Low: $-5M High: $-139.99K avg. 94.38% | Avg: $-3.82M Low: $-10.4M High: $-359.99K avg. -114.60% | Avg: $-9.75M Low: $-26.54M High: $-918.84K avg. -155.23% | Avg: $-51.04M Low: $-138.96M High: $-4.81M avg. -423.51% |
EPS
% change YoY
| -$0.45 N/A | -$0.44 2.22% | -$0.6 -36.36% | Avg: -$0.46 Low: -$0.47 High: -$0.44 avg. 24.16% | Avg: -$0.55 Low: -$1.78 High: $0.1 avg. -20.87% | Avg: -$0.63 Low: -$2.04 High: $0.11 avg. -14.54% | Avg: -$0.18 Low: -$0.58 High: $0.03 avg. 71.42% |
Operating Expenses
% change YoY
| $16.34M N/A | $20.06M 22.76% | $32.07M 59.86% | Avg: $129.50M Low: $10.18M High: $363.79M avg. 303.75% | Avg: $277.93M Low: $26.19M High: $756.68M avg. 114.60% | Avg: $709.39M Low: $66.85M High: $1.93B avg. 155.23% | Avg: $3.71B Low: $349.99M High: $10.11B avg. 423.51% |
FAQ
What is AIM ImmunoTech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.58% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -22.83M, average is -25.62M and high is -21.37M.
What is AIM ImmunoTech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 368.63% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $139.99K, average is $1.78M and high is $5M.
What is AIM ImmunoTech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.04% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.47, average is -$0.46 and high is $-0.44.